inhibitory glp 1 GLP-1 Drugs: For Multiple Chronic Conditions Diabetic Agents, From Metformin to

CesarTSalgaoMKMesaVSartorattoASivieriK

I., et al., Adjuvant Treatment and Onset of Menopause Predict Weight Gain After Breast Cancer Diagnosis, Journal of Clinical Oncology 17 (1999): 120129

Sublingual (under-the-tongue) GLP-1 agonists, such as semaglutide, represent a novel approach, promising similar benefits to injectable versions without the need for needles

This approach may appeal to patients who: prefer branded therapy first want compounded medication only as a backup during shortage disruption are uncomfortable using a provider whose business model depends heavily on compounding Mochi Healths Position Mochi is much more directly exposed to the compounding conversation because affordable compounded access is core to its value proposition

Asami T, Nishizawa N, Nida A, et al